iNtODEWORLD | Inside Intron
16537
page,page-id-16537,page-template,page-template-full_width,page-template-full_width-php,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,qode_grid_1300,qode-theme-ver-11.0,qode-theme-bridge,wpb-js-composer js-comp-ver-5.1.1,vc_responsive

AMR-web_BANNER_403x403px

Geneva, 18 January 2018 – The AMR Industry Alliance launches its first report that shows the commitment of the life sciences industry to tackle the public health threat of antimicrobial resistance (AMR). The Alliance brings together over 100 biotech, diagnostics, generics and research-based biopharmaceutical companies...

그림1

iNtRON Biotechnology held SAL200’s Phase 1b MAD study initiation meeting at Seoul National University Hospital on January 16th, 2018. Designated clinical research center, Seoul National University’s professors, doctors, nurses and other related participants to this study attended the meeting, and discussed detailed study process and...

123

  iNtRON Biotechnology has been conducting evaluation tests on the recombinant phage endolysins AP50-31 and LysB4, to validate their bacteriolytic properties against Bacillus genus. As a result, AP50-31 and LysB4 displayed rapid bacteriolytic activity against broad spectrum of Bacillus genus including Bacillus anthracis strains, and...

3

Global Shrimp Production Status Shrimp is a globally beloved food. Since it contains high-quality protein, calcium, minerals and vitamin B complexes, global demands for shrimps have constantly increased. Shrimps are mainly produced in China and Southeast Asia (Thailand, Vietnam and Indonesia), Latin America and India; more than...

4

iNtRON’s R&D Center was invited to “3rd World Congress and Exhibition on Antibiotics and Antibiotics Resistance“ as a speaker, in recognition of its study on SAL200. The topic of the conference was ‘The future of antibiotics: key opportunities & emerging therapies’, and prominent researchers from...

FDA-Meeting-on-Patient-Focused-Drug-Development-for-Bleeding-Disorders

The Food and Drug Administration (FDA), Center for Biologics Evaluation and Research, and the National Institutes of Health, National Institute of Allergy and Infectious Diseases held a public workshop entitled “Bacteriophage Therapy: Scientific and Regulatory Issues.” The purpose of the public workshop is to exchange...

iNtODEWORLD, Inc is the US subsidiary of iNtRON Biotechnology, Inc.